Photodegradation of the mycobacterium ulcerans toxin, mycolactones: Considerations for handling and storage

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Marion, Estelle ^a,b   Prado, Soizic ^c   Cano, Camille ^a   Babonneau, Jérémie ^a   Ghamrawi, Sarah ^b   Marsollier, Laurent ^a,b  

^a Team 12   (France)

^b ANGERS UNIVERSITY HOSPITAL   (France)

^c MUSÉUM NATIONAL D'HISTOIRE NATURELLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TOXIN; MYCOLACTONE; UNCLASSIFIED DRUG; MACROLIDE;

ARTICLE; BIOLOGICAL ACTIVITY; CONTROLLED STUDY; CYTOTOXICITY TEST; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LABORATORY DIAGNOSIS; LIGHT EXPOSURE; MASS SPECTROMETRY; MOLECULAR STABILITY; MYCOBACTERIUM ULCERANS; NONHUMAN; PHOTODEGRADATION; PHOTOSENSITIVITY; PROTON NUCLEAR MAGNETIC RESONANCE; SOLVENT EFFECT; SUNLIGHT; TEMPERATURE SENSITIVITY; TOXIN ANALYSIS; TOXIN STRUCTURE; TOXIN SYNTHESIS; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; ULTRAVIOLET C RADIATION; CHEMISTRY; LIGHT; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHOTOLYSIS; TEMPERATURE; ULTRAVIOLET RADIATION;

BACILLI (CLASS); MYCOBACTERIUM ULCERANS;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; LIGHT; MACROLIDES; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; MYCOBACTERIUM ULCERANS; PHOTOLYSIS; TEMPERATURE; ULTRAVIOLET RAYS;

EID: 84859726273     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0033600     Document Type: Article

References (26)

1. Asiedu K, Sherpbier R, Raviglione MC, (2000) Buruli Ulcer Mycobacterium ulcerans infection. W.H.O. Global Buruli Ulcer initiative. Report 2000 World Health Organisation Geneva Switzerland.
2. WorldHealthOrganization (2004) Buruli ulcer. Mycobacterium ulcerans infection. WER 79: 145-149.
3. Marion E, Landier J, Boisier P, Marsollier L, Fontanet A, et al. (2011) Geographic expansion of Buruli ulcer disease, Cameroon. Emerg Infect Dis 17: 551-553.
4. Asiedu K, Etuaful S, (1998) Socioeconomic implications of Buruli ulcer in Ghana: a three-year review. Am J Trop Med Hyg 59: 1015-1022.
5. Stienstra Y, van Roest MH, van Wezel MJ, Wiersma IC, Hospers IC, et al. (2005) Factors associated with functional limitations and subsequent employment or schooling in Buruli ulcer patients. Trop Med Int Health 10: 1251-1257.
6. George KM, Chatterjee D, Gunawardana G, Welty D, Hayman J, et al. (1999) Mycolactone: a polyketide toxin from Mycobacterium ulcerans required for virulence. Science 283: 854-857.
7. George KM, Pascopella L, Welty DM, Small PL, (2000) A Mycobacterium ulcerans toxin, mycolactone, causes apoptosis in guinea pig ulcers and tissue culture cells. Infect Immun 68: 877-883.
8. Stinear TP, Mve-Obiang A, Small PL, Frigui W, Pryor MJ, et al. (2004) Giant plasmid-encoded polyketide synthases produce the macrolide toxin of Mycobacterium ulcerans. Proc Natl Acad Sci U S A 101: 1345-1349.
9. Mve-Obiang A, Lee RE, Portaels F, Small PL, (2003) Heterogeneity of mycolactones produced by clinical isolates of Mycobacterium ulcerans: implications for virulence. Infect Immun 71: 774-783.
10. Ranger BS, Mahrous EA, Mosi L, Adusumilli S, Lee RE, et al. (2006) Globally distributed mycobacterial fish pathogens produce a novel plasmid-encoded toxic macrolide, mycolactone F. Infect Immun 74: 6037-6045.
11. Mve-Obiang A, Lee RE, Umstot ES, Trott KA, Grammer TC, et al. (2005) A newly discovered mycobacterial pathogen isolated from laboratory colonies of Xenopus species with lethal infections produces a novel form of mycolactone, the Mycobacterium ulcerans macrolide toxin. Infect Immun 73: 3307-3312.
12. Pidot SJ, Asiedu K, Kaser M, Fyfe JA, Stinear TP, (2010) Mycobacterium ulcerans and other mycolactone-producing mycobacteria should be considered a single species. PLoS Negl Trop Dis 4: e663.
13. Marsollier L, Brodin P, Jackson M, Kordulakova J, Tafelmeyer P, et al. (2007) Impact of Mycobacterium ulcerans biofilm on transmissibility to ecological niches and Buruli ulcer pathogenesis. PLoS Pathog 3: e62.
14. Coutanceau E, Marsollier L, Brosch R, Perret E, Goossens P, et al. (2005) Modulation of the host immune response by a transient intracellular stage of Mycobacterium ulcerans: the contribution of endogenous mycolactone toxin. Cell Microbiol 7: 1187-1196.
15. Fraga AG, Cruz A, Martins TG, Torrado E, Saraiva M, et al. (2011) Mycobacterium ulcerans triggers T-cell immunity followed by local and regional but not systemic immunosuppression. Infect Immun 79: 421-430.
16. Etuaful S, Carbonnelle B, Grosset J, Lucas S, Horsfield C, et al. (2005) Efficacy of the combination rifampin-streptomycin in preventing growth of Mycobacterium ulcerans in early lesions of Buruli ulcer in humans. Antimicrob Agents Chemother 49: 3182-3186.
17. Spangenberg T, Kishi Y, (2010) Highly sensitive, operationally simple, cost/time effective detection of the mycolactones from the human pathogen Mycobacterium ulcerans. Chem Commun (Camb) 46: 1410-1412.
18. Liu R, Jin Q, Tao G, Shan L, Huang J, et al. (2010) Photodegradation kinetics and byproducts identification of the Aflatoxin B1 in aqueous medium by ultra-performance liquid chromatography-quadrupole time-of-flight mass spectrometry. J Mass Spectrom 45: 553-559.
19. Zorraquino MA, Althaus RL, Roca M, Molina MP, (2011) Heat treatment effects on the antimicrobial activity of macrolide and lincosamide antibiotics in milk. J Food Prot 74: 311-315.
20. Zhang J, Wang W, Lu X, Xu Y, Zhang X, (2010) The stability and degradation of a new biological pesticide, pyoluteorin. Pest Manag Sci 66: 248-252.
21. George KM, Barker LP, Welty DM, Small PL, (1998) Partial purification and characterization of biological effects of a lipid toxin produced by Mycobacterium ulcerans. Infect Immun 66: 587-593.
22. Pahlevan AA, Wright DJ, Andrews C, George KM, Small PL, et al. (1999) The inhibitory action of Mycobacterium ulcerans soluble factor on monocyte/T cell cytokine production and NF-kappa B function. J Immunol 163: 3928-3935.
23. Gunawardana G, Delphi Chatterjee D, George K, Patrick Brennan P, David Whittern D, et al. (1999) Characterization of Novel Macrolide Toxins, Mycolactones A and B, from a Human Pathogen, Mycobacterium ulcerans. J Am Chem Soc 121: 6092-6093.
24. Kim I, Tanaka H, (2009) Photodegradation characteristics of PPCPs in water with UV treatment. Environ Int 35: 793-802.
25. Smijs TG, Pavel S, (2011) The susceptibility of dermatophytes to photodynamic treatment with special focus on Trichophyton rubrum. Photochem Photobiol 87: 2-13.
26. Ammad S, Gonzales M, Edwards C, Finlay AY, Mills C, (2008) An assessment of the efficacy of blue light phototherapy in the treatment of acne vulgaris. J Cosmet Dermatol 7: 180-188.